White blood cell count and c-reactive protein are independent predictors of mortality in the oldest old

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 65 A, Issue 7, 2010, Pages 764-768

  Willems, Jorien M ^a   Trompet, Stella ^a   Blauw, Gerard J ^a   Westendorp, Rudi G J ^a   De Craen, Anton J M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

CRP; Mortality; Older participants; White blood cell

Indexed keywords

C REACTIVE PROTEIN;

AGED; ARTICLE; CONFIDENCE INTERVAL; FEMALE; HUMAN; LEUKOCYTE COUNT; LONGITUDINAL STUDY; MALE; MORTALITY; PREDICTION AND FORECASTING; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SEX DIFFERENCE; SMOKING; STATISTICS;

AGED, 80 AND OVER; C-REACTIVE PROTEIN; CONFIDENCE INTERVALS; FEMALE; HUMANS; LEUKOCYTE COUNT; LONGITUDINAL STUDIES; MALE; MORTALITY; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEX FACTORS; SMOKING;

EID: 77953994047     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glq004     Document Type: Article

References (29)

1. Kannel WB, Anderson K, Wilson PW. White blood cell count and cardiovascular disease. insights from the Framingham Study. JAMA. 1992;267(9):1253-1256.
2. Prentice RL, Szatrowski TP, Fujikura T, Kato H, MAson MW, Hamilton HH. Leukocyte counts and coronary heart disease in a Japanese cohort. Am J Epidemiol. 1982;116(3):496-509.
3. Folsom AR, Wu KK, Rosamond WD, Sharrett AR, Chambless LE. Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARiC) Study. Circulation. 1997;96(4):1102-1108.
4. Gillum RF, Ingram DD, MAkuc DM. White blood cell count, Coronary heart disease, and death: the NhANeS i epidemiologic Follow-up Study. Am Heart J. 1993;125(3):855-863.
5. Weijenberg MP, Feskens EJ, Kromhout D. White blood cell count and the risk of coronary heart disease and all-cause mortality in elderly men. Arterioscler Thromb Vasc Biol. 1996;16(4): 499-503.
6. De Labry LO, Campion EW, Glynn RJ, Vokonas PS. White blood cell count as a predictor of mortality: results over 18 years from the Normative Aging Study. J Clin Epidemiol. 1990;43(2):153-157.
7. Lee CD, Folsom AR, Nieto FJ, Chambless LE, Shahar E, Wolfe DA. White blood cell count and incidence of coronary heart disease and ischemic stroke and mortality from cardiovascular disease in African-American and White men and women: atherosclerosis risk in communities study. Am J Epidemiol. 2001;154(8):758-764.
8. Jee SH, Park JY, Kim HS, Lee T Y, Samet JM. White blood cell count and risk for all-cause, Cardiovascular, and cancer mortality in a cohort of Koreans. Am J Epidemiol. 2005;162(11):1062-1069.
9. Ruggiero C, Metter EJ, Cherubini A, et al. White blood cell count and mortality in the BAltimore Longitudinal Study of Aging. J Am Coll Cardiol. 2007;49(18):1841-1850.
10. Brown DW, Giles WH, Croft JB. White blood cell count: an independent predictor of coronary heart disease mortality among a national cohort. J Clin Epidemiol. 2001;54(3):316-322.
11. MArgolis KL, MAnson JE, Greenland P, et al. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's health initiative Observational Study. Arch Intern Med. 2005;165(5):500-508.
12. MArgolis KL, Rodabough RJ, Thomson CA, Lopez AM, Mctiernan A. Prospective study of leukocyte count as a predictor of incident breast, Colorectal, Endometrial, and lung cancer and mortality in postmenopausal women. Arch Intern Med. 2007;167(17): 1837-1844.
13. tamakoshi K, ToyoshiMA H, Yatsuya H, et al. White blood cell count and risk of all-cause and cardiovascular mortality in nationwide sample of Japanese\results from the NiPPON DAtA90. Circ J. 2007; 71(4):479-485.
14. Boekholdt SM, Hack CE, Sandhu MS, et al. C-reactive protein levels and coronary artery disease incidence and mortality in apparently healthy men and women: the ePiC-Norfolk prospective population study 1993-2003. Atherosclerosis. 2006;187(2):415-422.
15. Danesh J, Wheeler JG, Hirschfeld GM, et al. C-reactive protein and other circulating MArkers of infammation in the prediction of coronary heart disease. N Engl J Med. 2004;350(14):1387-1397.
16. Pai JK, Pischon T, MA J, et al. infammatory MArkers and the risk of coronary heart disease in men and women. N Engl J Med. 2004;351(25):2599-2610. (Pubitemid 39628581)
17. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of frst cardiovascular events. N Engl J Med. 2002;347(20): 1557-1565.
18. Smit JJ, Ottervanger JP, Slingerland RJ, et al. Comparison of usefulness of C-reactive protein versus white blood cell count to predict outcome after primary percutaneous coronary intervention for St elevation myocardial infarction. Am J Cardiol. 2008;101(4):446-451.
19. Van der Wiel-Bootsma AB, Vanexel E, de Craen AJ, et al. A high response is not essential to prevent selection bias: results from the Leiden 85-plus study. J Clin Epidemiol. 2002;55(11):1119-1125.
20. Denelzen WP, Willems JM, Westendorp RG, de Craen AJ, Assendelft WJ, Gussekloo J. effect of anemia and comorbidity on functional status and mortality in old age: results from the Leiden 85-plus Study. CMAJ. 2009;181(3-4):151-157.
21. De Ruijter W, Westendorp RG, MAcfarlane PW, Jukema JW, Assendelft WJ, Gussekloo J. the routine electrocardiogram for cardiovascular risk stratifcation in old age: the Leiden 85-plus study. J Am Geriatr Soc. 2007;55(6):872-877.
22. Clarke R, Emberson JR, Breeze E, et al. Biomarkers of infammation predict both vascular and non-vascular mortality in older men. Eur Heart J. 2008;29(6):800-809.
23. Jylha M, Paavilainen P, Lehtimaki T, et al. interleukin-1 receptor antagonist, Interleukin-6, and C-reactive protein as predictors of mortality in nonagenarians: the vitality 90+ study. J Gerontol A Biol Sci Med Sci. 2007;62(9):1016-1021.
24. Kravitz BA, Corrada MM, Kawas CH. high levels of serum C-reactive protein are associated with greater risk of all-cause mortality, But not dementia, in the oldest-old: results from the 90+ Study. J Am Geriatr Soc. 2009;57(4):641-646.
25. Alexander RW. infammation and coronary artery disease. N Engl J Med. 1994;331(7):468-469.
26. Timpson NJ, Lawlor DA, Harbord RM, et al. C-reactive protein and its role in metabolic syndrome: Mendelian randomisation study. Lancet. 2005;366(9501):1954-1959.
27. Davey SG, Lawlor DA, Harbord R, et al. Association of C-reactive protein with blood pressure and hypertension: life course confounding and Mendelian randomization tests of causality. Arterioscler Thromb Vasc Biol. 2005;25(5):1051-1056.
28. Elliott P, Chambers JC, Zhang W, et al. Genetic loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA. 2009;302(1):37-48.
29. Pocock SJ, Ashby D, Shaper AG, Walker M, Broughton PM. Diurnal variations in serum biochemical and haematological measurements. J Clin Pathol. 1989;42(2):172-179.